东星医疗：公司与上海交通大学的合作项目目前进展顺利

Core Viewpoint - Dongxing Medical (301290) is making progress in its collaboration project with Shanghai Jiao Tong University, focusing on the construction of production lines for both long-chain and short-chain recombinant type III humanized collagen strains [1] Group 1 - The company is accelerating the development of its production lines for collagen strains [1] - The research results of the project are uncertain, and investors are advised to be cautious regarding investment risks [1]